2. NMA results for OS (MSKCC favourable risk groups).

Results of network meta‐analysis for outcome overall survival (MSKCC favourable risk group). Treatments are ordered by P‐Score (descending). Only subnetworks with >1 designs. Upper triangle: direct estimate. Lower triangle: network estimate. Subnet 1 No. of studies: 3. No. of pairwise comparisons: 3. No. of treatments: 4. No. of designs: 3 Heterogeneity/Inconsistency: Q = 0, df = 0, p=n.a.; I²=n.a., Tau²=n.a. Treatment Effects + 95%‐CIs (Hazard ratios, random‐effects model):
LEN+EVE	.	.	0.54 [0.21, 1.37]
0.62 [0.23, 1.65]	PAZ	.	0.88 [0.63, 1.21]
0.63 [0.18, 2.16]	1.02 [0.43, 2.44]	LEN+PEM	0.86 [0.38, 1.93]
0.54 [0.21, 1.37]	0.88 [0.63, 1.21]	0.86 [0.38, 1.93]	SUN
Subnet 2 No. of studies: 3. No. of pairwise comparisons: 3. No. of treatments: 4. No. of designs: 3 Heterogeneity/Inconsistency: Q = 0, df = 0, P = n.a.; I²=n.a., Tau² = n.a. Treatment Effects + 95%‐CIs (Hazard Ratios, random effects model):
IFN+BEV	.	0.92 [0.62, 1.37]	0.90 [0.64, 1.25]
0.93 [0.58, 1.49]	NAP+IFN	.	0.96 [0.69, 1.34]
0.92 [0.62, 1.37]	0.99 [0.53, 1.83]	IFN+PLA	.
0.89 [0.64, 1.25]	0.96 [0.69, 1.34]	0.97 [0.58, 1.64]	IFN